A substantial body of research has employed advanced sequencing technologies, including genomics and transcriptome sequencing, to identify potential biomarkers linked to the diagnosis and prognosis of GC, such as COL4A1, Chitinase-3-like protein-1 (CHI3L1), and various miRNAs. This evidence concerns the gene CHI3L1 and gastric cancer.